Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fluticasone propionate + formoterol fumarate (Libbs Farmacêutica)
- Development stage
- Unknown
- Lead developer
- Libbs Farmacêutica
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
Duonare is a brand name for a fixed-dose combination (FDC) of fluticasone propionate and formoterol fumarate, developed by Libbs Pharmaceutical for the maintenance treatment of asthma in adults. Fluticasone propionate is an inhaled corticosteroid (ICS) that exerts potent anti-inflammatory effects by binding to glucocorticoid receptors in the airways, reducing swelling and irritation. Formoterol fumarate is a long-acting beta-2 adrenergic agonist (LABA) that provides rapid and sustained bronchodilation by relaxing airway smooth muscle. The product is delivered via a dry powder inhaler (DPI) and has been evaluated in clinical trials in Brazil, demonstrating comparable efficacy and safety to other established ICS/LABA combinations such as budesonide/formoterol.
- Brand names
- Duonare
- Other names
- fluticasone propionate/formoterol fumaratefluticasone/formoterol
02
Targets
ADRB1 (β1)ADRB2 (β2)ADRB3 (β3)PR (Progesterone receptor)GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on fluticasone propionate + formoterol fumarate (Libbs Farmacêutica).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fluticasone propionate + formoterol fumarate (Libbs Farmacêutica).